Clinical Outcomes of Inferior Turbinate Reduction Surgery in Patients with Allergic Rhinitis: A Prospective Observational Study
International Journal of Current Pharmaceutical Review and Research · 31.05.2026 · 18 (05)
DOI: 10.25258/ijcpr.18.5.114 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 31.05.2026. Verfasst von Reema Goswami und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Allergic rhinitis is a chronic inflammatory disorder of the nasal mucosa characterized by nasal obstruction, rhinorrhoea, sneezing, and itching, significantly affecting quality of life. Persistent nasal obstruction secondary to inferior turbinate hypertrophy may remain refractory to medical treatment, necessitating surgical intervention. Inferior turbinate reduction surgery aims to improve nasal airflow while preserving mucosal function. The present study evaluated the clinical outcomes of inferior turbinate reduction surgery in patients with allergic rhinitis. Aim and Objective: To assess the efficacy of inferior turbinate reduction surgery in patients with allergic rhinitis using postoperative symptomatic improvement, Total Nasal Symptom Score (TNSS), nasal airway patency, and clinical outcomes. Materials and Methods: A prospective observational study was conducted in the Department of Otorhinolaryngology at Bundelkhand Medical College, Sagar, Madhya Pradesh, India, over 18 months (September 2023–February 2025). Ninety patients with allergic rhinitis associated with inferior turbinate hypertrophy and persistent symptoms despite medical therapy were included. Patients underwent submucosal inferior turbinate reduction surgery and were followed up for 90 days postoperatively. Clinical evaluation included TNSS assessment, anterior rhinoscopy, diagnostic nasal endoscopy, assessment of nasal airway patency, and postoperative healing.
Results
Among the 90 participants, the majority belonged to the 18–25-year age group (43.3%), with a mean age of 31.8 years, and males constituted 70% of the study population. Nasal obstruction was the most common presenting symptom (90%), followed by rhinorrhoea (71%). Mean TNSS significantly decreased from 10.4 preoperatively to 5.4 at 90 days postoperatively (p
Zitieren
APA
Goswami, R., Jain, D., & Sharafudeen, F. (2026). Clinical Outcomes of Inferior Turbinate Reduction Surgery in Patients with Allergic Rhinitis: A Prospective Observational Study. International Journal of Current Pharmaceutical Review and Research, 18(05). https://doi.org/10.25258/ijcpr.18.5.114
Vancouver
Goswami R, Jain D, Sharafudeen F. Clinical Outcomes of Inferior Turbinate Reduction Surgery in Patients with Allergic Rhinitis: A Prospective Observational Study. International Journal of Current Pharmaceutical Review and Research. 2026;18(05). doi:10.25258/ijcpr.18.5.114
BibTeX
@article{Goswami2026,
author = {Goswami, Reema and Jain, Dinesh and Sharafudeen, Fathima},
title = {Clinical Outcomes of Inferior Turbinate Reduction Surgery in Patients with Allergic Rhinitis: A Prospective Observational Study},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {05},
doi = {10.25258/ijcpr.18.5.114}
}
EUVIMED